Other OTC Pharmaceuticals (Pharmacies) - Republic of the Congo

  • Republic of the Congo
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$1.41m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.25%, resulting in a market volume of US$1.50m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.23 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Republic of the Congo is experiencing significant development and growth. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this positive trajectory. Customer preferences in the Other OTC Pharmaceuticals (Pharmacies) market in Republic of the Congo are driving the growth of the industry. Consumers in the country are increasingly seeking convenience and accessibility when it comes to healthcare products. They prefer to have easy access to over-the-counter medications and other healthcare products without the need for a prescription. This preference for self-care and self-medication is fueling the demand for OTC pharmaceuticals in pharmacies across the country. Trends in the market also play a significant role in the development of the Other OTC Pharmaceuticals (Pharmacies) market in Republic of the Congo. The increasing urbanization and population growth in the country are contributing to the expansion of the pharmaceutical retail sector. As more people move to urban areas, the demand for OTC medications and healthcare products is rising. Pharmacies are expanding their product offerings and services to cater to the growing needs of the population. Local special circumstances in Republic of the Congo further contribute to the development of the Other OTC Pharmaceuticals (Pharmacies) market. The country has a relatively low doctor-to-patient ratio, which means that access to healthcare professionals for minor ailments may be limited. As a result, consumers rely on pharmacies and OTC medications to manage their health issues. The convenience and affordability of OTC pharmaceuticals make them a popular choice for self-treatment. Underlying macroeconomic factors also play a role in the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Republic of the Congo. The country's improving economic conditions and rising disposable incomes have increased the purchasing power of consumers. This allows them to spend more on healthcare products, including OTC medications. Additionally, the government's focus on improving healthcare infrastructure and access to essential medications has created a favorable environment for the growth of the OTC pharmaceutical market. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Republic of the Congo is experiencing significant development and growth due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The demand for convenience and accessibility, increasing urbanization, low doctor-to-patient ratio, improving economic conditions, and government initiatives all contribute to the positive trajectory of the market. As the country continues to develop and the population grows, the OTC pharmaceutical market is expected to thrive.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)